FDA Investigating Contaminated Metformin, Risk is Low for Type 2 Patients

The FDA, Health Canada, and European Union investigate the presence of cancer-causing NDMA in Type 2 diabetes drug, metformin. The risk to patients is very low.

Non-Insulin Drug Approved for Kids with T2D by FDA

Victoza, a liraglutide injection, was approved by the U.S. Food and Drug Administration. It's the first non-insulin drug approved for pediatric use in nearly 20 years.